Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  52 results for ""Cyclin-Dependent Kinase Inhibitor p15""

Your Filters

Publisher : american association for cancer research
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B Status in IDH-Mutant Astrocytomas.

  • Authors : Lee MD; Department of Radiology, NYU Grossman School of Medicine, New York, New York.; Jain R

Subjects: DNA Methylation* ; Astrocytoma*/Astrocytoma*/Astrocytoma*/genetics ; Astrocytoma*/Astrocytoma*/Astrocytoma*/pathology

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 15; Vol. 30 (16), pp. 3512-3519.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study.

Subjects: Cyclin-Dependent Kinase Inhibitor p15*; Lymphocytes, Tumor-Infiltrating/Lymphocytes, Tumor-Infiltrating/Lymphocytes, Tumor-Infiltrating/*pathology ; Melanoma/Melanoma/Melanoma/*genetics

  • Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Identification of De Novo Enhancers Activated by TGFβ to Drive Expression of CDKN2A and B in HeLa Cells.

  • Authors : Liu YT; Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.; Xu L

Subjects: Enhancer Elements, Genetic*; Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/*genetics ; Cyclin-Dependent Kinase Inhibitor p16/Cyclin-Dependent Kinase Inhibitor p16/Cyclin-Dependent Kinase Inhibitor p16/*genetics

  • Source: Molecular cancer research : MCR [Mol Cancer Res] 2019 Sep; Vol. 17 (9), pp. 1854-1866. Date of Electronic Publication: 2019 Jun 12.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.

  • Authors : McNeal AS; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Liu K

Subjects: Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/*deficiency ; Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/*genetics ; Melanoma/Melanoma/Melanoma/*genetics

  • Source: Cancer discovery [Cancer Discov] 2015 Oct; Vol. 5 (10), pp. 1072-85. Date of Electronic Publication: 2015 Jul 16.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.

  • Authors : Megquier K; Broad Institute of Harvard and MIT, Cambridge, Massachusetts. .; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Subjects: Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/*genetics ; Cyclin-Dependent Kinase Inhibitor p16/Cyclin-Dependent Kinase Inhibitor p16/Cyclin-Dependent Kinase Inhibitor p16/*genetics ; Hemangiosarcoma/Hemangiosarcoma/Hemangiosarcoma/*genetics

  • Source: Molecular cancer research : MCR [Mol Cancer Res] 2019 Dec; Vol. 17 (12), pp. 2410-2421. Date of Electronic Publication: 2019 Sep 30.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16).

  • Authors : Markus J; Laboratory of Cellular Oncology, National Cancer Institute and National Human Genome Research Institute/NIH, 37 Convent Drive, Bethesda, MD 20892, USA.; Garin MT

Subjects: Chromosome Inversion* ; Chromosomes, Human, Pair 6*; Core Binding Factor beta Subunit/Core Binding Factor beta Subunit/Core Binding Factor beta Subunit/*genetics

  • Source: Cancer research [Cancer Res] 2007 Feb 01; Vol. 67 (3), pp. 992-1000.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.

  • Authors : Zhang S; Sichuan University, Chengdu 610041, Sichuan Province, People's Republic of China.; Tang Q

Subjects: Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/*metabolism ; Cyclin-Dependent Kinase Inhibitor p16/Cyclin-Dependent Kinase Inhibitor p16/Cyclin-Dependent Kinase Inhibitor p16/*metabolism ; Cyclin-Dependent Kinase Inhibitor p18/Cyclin-Dependent Kinase Inhibitor p18/Cyclin-Dependent Kinase Inhibitor p18/*metabolism

  • Source: Molecular cancer research : MCR [Mol Cancer Res] 2009 Apr; Vol. 7 (4), pp. 570-80.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts.

  • Authors : Carbone CJ; Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.; Graña X

Subjects: Genes, bcl-2*; Cell Transformation, Neoplastic/Cell Transformation, Neoplastic/Cell Transformation, Neoplastic/*genetics ; Cyclin-Dependent Kinase 4/Cyclin-Dependent Kinase 4/Cyclin-Dependent Kinase 4/*genetics

  • Source: Cancer research [Cancer Res] 2007 May 01; Vol. 67 (9), pp. 4130-7.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF.

  • Authors : Pasmant E; Laboratoire de Génétique Moléculaire-Institut National de la Sante et de la Recherche Medicale U745, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris V.; Laurendeau I

Subjects: Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/*genetics ; Cyclin-Dependent Kinase Inhibitor p16/Cyclin-Dependent Kinase Inhibitor p16/Cyclin-Dependent Kinase Inhibitor p16/*genetics ; Melanoma/Melanoma/Melanoma/*genetics

  • Source: Cancer research [Cancer Res] 2007 Apr 15; Vol. 67 (8), pp. 3963-9.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma.

  • Authors : Jafri M; Medical and Molecular Genetics, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Department of Oncology, University Hospital Birmingham Foundation Trust, Birmingham, United Kingdom.; Wake NC

Subjects: Germ-Line Mutation*; Carcinoma, Renal Cell/Carcinoma, Renal Cell/Carcinoma, Renal Cell/*genetics ; Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/Cyclin-Dependent Kinase Inhibitor p15/*genetics

  • Source: Cancer discovery [Cancer Discov] 2015 Jul; Vol. 5 (7), pp. 723-9. Date of Electronic Publication: 2015 Apr 14.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model:

Record details

Read More Add to Saved list
×
  • 1-10 of  52 results for ""Cyclin-Dependent Kinase Inhibitor p15""